A PHASE 1B STUDY OF NIKTR-102 IN COMBINATION WITH PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN PATIENTS WITH ADVANCED/METASTATIC REFRACTORY SOLID TUMORS
|Effective start/end date||10/1/11 → 9/30/12|
- NEKTAR THERAPEUTICS
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.